NDC 13668-0014 - Levetiracetam
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 13668-0014
- Manufacturer
- Rebel Distributors Corp
- Effective date
- 2010-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Levetiracetam - Rebel Distributors Corp | Rebel Distributors Corp | 2010-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| LEVETIRACETAM | ACTIVE INGREDIENT | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 | |
| LEVETIRACETAM | ACTIVE MOIETY | 44YRR34555 | LEVETIRACETAM TABLET [REBEL DISTRIBUTORS CORP] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam | LEVETIRACETAM IN SODIUM CHLORIDE | Eugia US LLC | e5eb4c89-8ee9-4474-9cb1-c3b3dc262a4a | 2024-04-01 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Solco healthcare U.S., LLC | bc8644ed-3320-47b5-adf3-8b972bea8abd | 2024-03-28 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | 57f09129-7151-4a75-9d73-9dd32f74ba43 | 2024-03-27 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Solco Healthcare US, LLC | dd713e60-478c-43cd-b680-ff594a0b3864 | 2024-03-27 | Warnings, Adverse reactions | 311288 387003 311290 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | PAI Holdings, LLC dba PAI Pharma | 9dca1330-52ca-47a4-a134-ec55c9d5786d | 2024-03-27 | Warnings, Adverse reactions | 44YRR34555 |
| ELEPSIA XR 1000 MG | LEVETIRACETAM | TRIPOINT THERAPEUTICS, LLC | cac83d47-88a2-4447-a0c0-90b44ffda0ac | 2024-03-25 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Gland Pharma Limited | aa883d9c-c6cd-44ab-a1de-058985e4f97f | 2024-03-25 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Mylan Institutional LLC | 70e52e89-3844-4cd9-a406-b29e9520a12c | 2024-03-15 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Proficient Rx LP | 6bdbc193-d86b-4bd5-8e88-4ea964d2cdde | 2024-03-01 | Warnings, Adverse reactions | 311289 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Patrin Pharma, Inc. | 49117cee-a96c-4593-91a7-8a133e3f0939 | 2024-02-15 | Warnings, Adverse reactions | 44YRR34555 |
| levetiracetam | LEVETIRACETAM | MAJOR PHARMACEUTICALS | 6913c611-4994-4501-8ed9-45161f90373e | 2023-12-28 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | WG Critical Care, LLC | 5e5b0ed3-b104-45a7-bb3e-ee56febb46e8 | 2023-10-30 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Natco Pharma USA LLC | 34af3602-0188-4d2e-904b-2e40000bb45c | 2023-08-05 | Warnings, Adverse reactions | 44YRR34555 |
| LEVETIRACETAM | LEVETIRACETAM | Armas Pharmaceuticals Inc. | 7be45c40-8d75-4c40-97a4-95067129bc2a | 2023-07-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam ER | LEVETIRACETAM | Proficient Rx LP | a0ad8200-70c9-4f4f-86c5-4a8c6c9f0223 | 2022-12-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam ER | LEVETIRACETAM | Proficient Rx LP | 57b9dccb-6ee6-4e89-ab26-4c478e2df2b5 | 2022-04-01 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Fresenius Kabi USA, LLC | cc4a06f1-6509-4650-b20c-259a39353733 | 2022-02-28 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM | Fresenius Kabi USA, LLC | cc41696c-9cf0-4410-bacc-09132ee805ce | 2022-01-24 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM INJECTION | Dr.Reddy's Laboratories Inc | be8ec971-c4f1-3e53-77e1-8337d9d506eb | 2021-12-31 | Warnings, Adverse reactions | 44YRR34555 |
| Levetiracetam | LEVETIRACETAM INJECTION | Dr.Reddy's Laboratories Inc | 0a9234b7-46b1-8e6c-a992-90f86cfb6e00 | 2021-12-31 | Warnings, Adverse reactions | 44YRR34555 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.